fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ACC 2014 Report: Benefits of treating heart attack patients with a cheap drug

Written by | 23 Apr 2014

The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.

ACC 2014 Report: Aleglitaza does not reduce risk of CV events in diabetics

Written by | 23 Apr 2014

Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death,… read more.

ACC 2014 Report: ACE Inhibitors better than ARBs in CV patients with diabetes

Written by | 23 Apr 2014

Report from the ACC Annual Scientific Meeting, 29 – 31 March 2014 in Washington.   Angiotensin-converting-enzyme (ACE) inhibitors are associated with reduced mortality and cardiovascular events in patients… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.